Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $94.17 +1.15%
EPS Growth %: -1.5%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -1.5%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q1 EPS of $1.45, $0.06 better than the analyst estimate of $1.39. Revenue for the quarter came in at $9.8 billion versus the consensus estimate of $9.55 billion.
GUIDANCE:
Medtronic sees FY2027 EPS of $5.94-$6.00, versus the consensus of $5.95.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
